文献速递慢性肾脏病

多学科综合干预对非糖尿病CKD不良临床结局的系统评价与荟萃分析

Effectiveness of Multifaceted Care Approach on Adverse Clinical Outcomes in Nondiabetic CKD: A Systematic Review and Meta-analysis.
PubMed 文献 · Kidney Int Rep · 2017-02-16

该系统评价纳入5项研究,比较≥2种干预组合与常规诊疗对非糖尿病CKD患者的效果。综合干预使需要透析的肾衰竭进展风险降低(RR 0.57, 95%CI 0.35-0.94),全因死亡风险有降低趋势(RR 0.81, 95%CI 0.63-1.03),但未显著减少全因住院或改善血压控制。

要点

  • 综合干预可降低非糖尿病CKD患者进展至透析的风险。
  • 全因死亡风险有降低趋势但未达统计学显著。
  • 全因住院和血压控制未见显著改善。

核心结论

  • 针对多风险因素的综合干预倾向于降低非糖尿病CKD患者全因死亡风险,并降低进展至终末期肾衰竭的风险。

主要发现

  • 与常规诊疗相比,综合干预使需要透析的肾衰竭进展风险降低(RR 0.57, 95%CI 0.35-0.94)。
  • 综合干预对全因死亡风险有降低趋势(RR 0.81, 95%CI 0.63-1.03)。
  • 综合干预未显著降低全因住院风险(RR 0.93, 95%CI 0.71-1.23)。
  • 综合干预未显著改善血压控制(均数差 -0.48, 范围 -2.5 至 1.55 mm Hg)。

关键数值与推荐

  • 综合干预定义为与常规诊疗相比,采用2种或以上干预组合。
  • 主要结局为不良临床结局风险降低(肾脏替代治疗、全因住院、全因和心血管死亡、心血管事件)。

临床怎么用

  • 对非糖尿病CKD患者可考虑采用针对多风险因素的综合干预以延缓肾衰竭进展。
  • 综合干预对全因死亡的获益尚需高质量研究进一步验证。

局限性

  • 仅5项研究符合纳入标准,证据基础有限。
  • 需要高质量研究严格评估针对CKD多管理领域的干预组合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The risk of major adverse events associated with chronic kidney disease (CKD) could potentially be reduced with effective medical interventions. The impact of multifaceted interventions as compared with usual care in patients with nondiabetic CKD is unclear. We performed a systematic review to analyze the impact of multifaceted interventions on reducing the risk of major adverse events in this population. METHODS: Systematic review and meta-analysis. We searched MEDLINE, EMBASE, CINAHL and the Cochrane Library databases for medical literature published up to November 2016. Published original studies and abstracts were reviewed that reported on adult patients in a community or specialty care setting, with 2 or more CKD risk factors, treated with a combination of more than 2 interventions. We included randomized controlled trials, observational studies, and systematic reviews. Studies focused on diabetic patients were excluded. The intervention was defined as a treatment with a combination of 2 or more interventions compared with the usual care. The outcomes were defined as a reduction in the risk of adverse clinical outcomes (renal replacement therapy, all-cause hospitalizations, all-cause and cardiovascular mortality, cardiovascular events) as primary outcomes. Secondary outcomes were optimal risk factor control (attaining guideline concordant blood pressure, reduction of proteinuria, smoking cessation). RESULTS: Five of the 5846 unique citations from our initial literature search met our study criteria. All identified studies reported on patients with CKD and their management. In comparison with usual care, multifaceted interventions tended to reduce all-cause mortality (risk ratio: 0.81, 95% confidence interval: 0.63-1.03) and were associated with a lower risk of progression to kidney failure requiring dialysis (risk ratio: 0.57, 95% confidence interval: 0.35-0.94). Multifaceted interventions were not associated with reducing risk of all-cause hospitalizations (risk ratio: 0.93, 95% confidence interval: 0.71-1.23) or improved blood pressure control (mean difference: -0.48, range: -2.5 to 1.55 mm Hg). DISCUSSION: Multifaceted interventions targeting multiple risk factors tended to reduce the risk of all-cause mortality and reduced the risk to progress to end-stage kidney failure in patients with CKD. There is a need for high-quality studies that can rigorously evaluate a set of interventions targeting multiple domains of CKD management in the population with nondiabetic CKD due to paucity of data in the current published literature.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Bello AK, Qarni B, Samimi A, et al. Effectiveness of Multifaceted Care Approach on Adverse Clinical Outcomes in Nondiabetic CKD: A Systematic Review and Meta-analysis. Kidney Int Rep. 2017. PMID: 29142980. doi:10.1016/j.ekir.2017.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。